Small Cell Lung Cancer Market The total Small-cell lung cancer incident cases are expected to increase with a CAGR of 1.7% for the study period 2017-30. Among the seven major markets, the US accounted for the highest Small Cell Lung Cancer incidence. As per DelveInsight, the Small cell lung cancer market size is expected to grow at a CAGR of 15.2% during the study period (2017–30). The key players in the Small Cell Lung Cancer Market includes Bristol-Myers Squibb, Merck, AstraZeneca, Genentech, G1 Therapeutics, PharmaMar, United Therapeutics, EpicentRx, Amgen, Fate Therapeutics, and many others. For more information on Small Cell Lung Cancer Market, visit: https://www.delveinsight.com/blog/small-cell-lung-cancer-market/